Articles

The ever more bumpy road towards lenient treatment

The ever more bumpy road towards lenient treatment

The ever more bumpy road towards lenient treatment

30.11.2015 NL law

There is no doubt that the introduction of amnesty or leniency programs in an increasing number of jurisdictions has been an important step in the fight against cartels. The majority of cartels that have been fined over the last 10 to 15 years have come to the attention of the relevant authorities via applications for lenient treatment.

Over the years, many companies confronted with the possible liability and very negative fall-out of being involved in a cartel (such as high fines and “jail time” for individuals), have chosen to confess and hand in evidence of illegal conduct to the authorities in exchange of lenient treatment. In particular for listed companies, an application for lenient treatment was “the right thing to do” in the context of damage control that could lead to no or reduced fines and jail time. In addition, cooperating with authorities and confessing illegal conduct was considered to be acting as a “good corporate citizen”.

This article has been published in Competition Law & Policy Debate 2015, 1, 14-15.

Read the full article.

Related news

05.04.2022 NL law
Game on for gatekeepers: Digital Markets Act finalised

Short Reads - Now that political agreement has been reached on the final text, the Digital Markets Act (DMA) will enter into force soon. The DMA’s ex ante rules and obligations will apply next to the ad hoc EU and national competition rules. Time for big digital companies to take stock of the potential implications of these additional rules on their day-to-day business operations. See our infographic for a concise overview of the DMA.

Read more

04.04.2022 EU law
ACM jumps on gun-jumping bandwagon

Short Reads - Companies involved in multi-step acquisitions should beware of potential gun-jumping risks. The Dutch Authority for Consumers and Markets (ACM) has fined a trade association for failing to notify the acquisition of four pharmacies involving a consecutive partial resale. Unlike the European Commission’s gun-jumping fine for partial implementation of a concentration through a ‘warehousing’ two-step acquisition (see our July 2019 newsletter; appeal pending), the ACM’s fine relates to faulty turnover calculations due to an unmaterialized two-step transaction.

Read more

04.04.2022 EU law
The ECN+ Directive implemented in Belgium and introduction of merger filing fees

Short Reads - On 7 March 2022, the Act implementing the ECN+ Directive into Belgian law was published in the Belgian Official Gazette. The Act entered into force on 17 March 2022. Some of the key amendments include (i) the introduction of filing fees for the notification of a concentration, (ii) new fines and penalty payments (including clarifications on the leniency programme), (iii) new dawn raid powers and (iv) the introduction of a regulatory framework for mutual assistance and cooperation within the European Competition Network.

Read more